Carcinoma in children with recurrent respiratory papillomas: An update

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 9, Issue 6, 2001, Pages 374-376

  Hartnick, Christopher J ^a,c   MacCallum, Patricia L ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b South East Health Care Corporation ^*  (Canada)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

CHILD; CHILDHOOD CANCER; HEAD AND NECK TUMOR; HUMAN; LARYNX PAPILLOMATOSIS; LARYNX TUMOR; MALIGNANT TRANSFORMATION; PAPILLOMA; PRIORITY JOURNAL; SHORT SURVEY; TUMOR RECURRENCE; WART VIRUS;

EID: 0035216021     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200112000-00007     Document Type: Short Survey

References (22)

1. Recurrent respiratory papillomatosis in children: A retrospective study of management and complications
2. Human papillomavirus type 6 and 11 DNA sequence in genital and laryngeal papillomas and in some cervical cancers
3. Human papillomaviruses: General features
4. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53
5. Pediatric respiratory papillomatosis: Prognostic role of viral typing and cofactors
6. Task force on recurrent respiratory papillomas. A preliminary report
7. Recurrent respiratory papillomatosis of the larynx: Current diagnosis and treatment
8. Pathogenesis and treatment of juvenile onset recurrent respiratory papillomatosis
9. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes
10. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis
11. Adult respiratory papillomatosis: Human papillomavirus type and viral coinfections as predictors of prognosis
12. Risk factors for juvenile onset recurrent respiratory papillomatosis
13. Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: Correlation of TAP-1 with disease
14. Expression of Ki-67, tumor suppressor proteins, growth factor, and growth factor receptor in juvenile respiratory papillomatosis: Ki-67 and p53 as predictors of aggressive disease
15. Growth and differentiation factors in tracheobronchial epithelium
16. Molecular themes in oncogenesis
17. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation
18. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67
19. Rapid Communication: Powered laryngeal shavers and laryngeal papillomatosis: A preliminary report
20. Use of a laryngeal micro resector system
21. The high photoactivity of m-THPC in photo-dynamic therapy. Unusually strong retention of m-THPC by RIF-1 cells in culture
22. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis